260 related articles for article (PubMed ID: 25297648)
1. Progress and challenges in the development of a cell-based therapy for hemophilia A.
Fomin ME; Togarrati PP; Muench MO
J Thromb Haemost; 2014 Dec; 12(12):1954-65. PubMed ID: 25297648
[TBL] [Abstract][Full Text] [Related]
2. In Utero Transplantation of Placenta-Derived Mesenchymal Stromal Cells for Potential Fetal Treatment of Hemophilia A.
Kumar P; Gao K; Wang C; Pivetti C; Lankford L; Farmer D; Wang A
Cell Transplant; 2018 Jan; 27(1):130-139. PubMed ID: 29562772
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic correction of hemophilia A by transplantation of hPSC-derived liver sinusoidal endothelial cell progenitors.
Gage BK; Merlin S; Olgasi C; Follenzi A; Keller GM
Cell Rep; 2022 Apr; 39(1):110621. PubMed ID: 35385743
[TBL] [Abstract][Full Text] [Related]
4. Transplantation of endothelial cells corrects the phenotype in hemophilia A mice.
Kumaran V; Benten D; Follenzi A; Joseph B; Sarkar R; Gupta S
J Thromb Haemost; 2005 Sep; 3(9):2022-31. PubMed ID: 16102109
[TBL] [Abstract][Full Text] [Related]
5. Production of factor VIII by human liver sinusoidal endothelial cells transplanted in immunodeficient uPA mice.
Fomin ME; Zhou Y; Beyer AI; Publicover J; Baron JL; Muench MO
PLoS One; 2013; 8(10):e77255. PubMed ID: 24167566
[TBL] [Abstract][Full Text] [Related]
6. Functional aspects of factor VIII expression after transplantation of genetically-modified hematopoietic stem cells for hemophilia A.
Ide LM; Iwakoshi NN; Gangadharan B; Jobe S; Moot R; McCarty D; Doering CB; Spencer HT
J Gene Med; 2010 Apr; 12(4):333-44. PubMed ID: 20209485
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic correction and stable expression of factor VIII in hemophilia A mice by embryonic stem cell therapy.
Wang JJ; Kuang Y; Zhang LL; Shen CL; Wang L; Lu SY; Lu XB; Fei J; Gu MM; Wang ZG
Genet Mol Res; 2013 May; 12(2):1511-21. PubMed ID: 23765957
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic correction of murine hemophilia A using an iPS cell-based therapy.
Xu D; Alipio Z; Fink LM; Adcock DM; Yang J; Ward DC; Ma Y
Proc Natl Acad Sci U S A; 2009 Jan; 106(3):808-13. PubMed ID: 19139414
[TBL] [Abstract][Full Text] [Related]
9. Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A.
Olgasi C; Talmon M; Merlin S; Cucci A; Richaud-Patin Y; Ranaldo G; Colangelo D; Di Scipio F; Berta GN; Borsotti C; Valeri F; Faraldi F; Prat M; Messina M; Schinco P; Lombardo A; Raya A; Follenzi A
Stem Cell Reports; 2018 Dec; 11(6):1391-1406. PubMed ID: 30416049
[TBL] [Abstract][Full Text] [Related]
10. Factor VIII can be synthesized in hemophilia A mice liver by bone marrow progenitor cell-derived hepatocytes and sinusoidal endothelial cells.
Yadav N; Kanjirakkuzhiyil S; Ramakrishnan M; Das TK; Mukhopadhyay A
Stem Cells Dev; 2012 Jan; 21(1):110-20. PubMed ID: 21480781
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cells encoding porcine factor VIII induce pro-coagulant activity in hemophilia A mice with pre-existing factor VIII immunity.
Doering CB; Gangadharan B; Dukart HZ; Spencer HT
Mol Ther; 2007 Jun; 15(6):1093-9. PubMed ID: 17387335
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of fetal liver cell transplantation in hemophilia A mice.
Merlin S; Akula S; Cottonaro A; Garcia-Leal T; Serrano LJ; Borroni E; Kalandadze V; Galiano R; Borsotti C; Liras A; Sanchez MJ; Follenzi A
Haematologica; 2023 Jun; 108(6):1544-1554. PubMed ID: 36700401
[TBL] [Abstract][Full Text] [Related]
13. Searching for a Cell-Based Therapeutic Tool for Haemophilia A within the Embryonic/Foetal Liver and the Aorta-Gonads-Mesonephros Region.
Serrano LJ; Cañete A; Garcia-Leal T; Tomás-Gallardo L; Flores AI; de la Torre P; Liras A; Sánchez MJ
Thromb Haemost; 2018 Aug; 118(8):1370-1381. PubMed ID: 29991091
[TBL] [Abstract][Full Text] [Related]
14. Development of improved factor VIII molecules and new gene transfer approaches for hemophilia A.
Saenko EL; Ananyeva NM; Moayeri M; Ramezani A; Hawley RG
Curr Gene Ther; 2003 Feb; 3(1):27-41. PubMed ID: 12553533
[TBL] [Abstract][Full Text] [Related]
15. Endothelial cells derived from patients' induced pluripotent stem cells for sustained factor VIII delivery and the treatment of hemophilia A.
Rose M; Gao K; Cortez-Toledo E; Agu E; Hyllen AA; Conroy K; Pan G; Nolta JA; Wang A; Zhou P
Stem Cells Transl Med; 2020 Jun; 9(6):686-696. PubMed ID: 32162786
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic approaches for treating hemophilia A using embryonic stem cells.
Kasuda S; Tatsumi K; Sakurai Y; Shima M; Hatake K
Hematol Oncol Stem Cell Ther; 2016 Jun; 9(2):64-70. PubMed ID: 27131224
[TBL] [Abstract][Full Text] [Related]
17. High-level expression of porcine factor VIII from genetically modified bone marrow-derived stem cells.
Gangadharan B; Parker ET; Ide LM; Spencer HT; Doering CB
Blood; 2006 May; 107(10):3859-64. PubMed ID: 16449528
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens.
Ide LM; Gangadharan B; Chiang KY; Doering CB; Spencer HT
Blood; 2007 Oct; 110(8):2855-63. PubMed ID: 17569821
[TBL] [Abstract][Full Text] [Related]
19. In Utero Cell Treatment of Hemophilia A Mice via Human Amniotic Fluid Mesenchymal Stromal Cell Engraftment.
Kao YT; Yen CC; Fan HC; Chen JK; Chen MS; Lan YW; Yang SH; Chen CM
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003601
[TBL] [Abstract][Full Text] [Related]
20. Potential long-term treatment of hemophilia A by neonatal co-transplantation of cord blood-derived endothelial colony-forming cells and placental mesenchymal stromal cells.
Gao K; Kumar P; Cortez-Toledo E; Hao D; Reynaga L; Rose M; Wang C; Farmer D; Nolta J; Zhou J; Zhou P; Wang A
Stem Cell Res Ther; 2019 Jan; 10(1):34. PubMed ID: 30670078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
